Product Code: ETC6653633 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Canada Companion Diagnostic Tests in Oncology Market Overview |
3.1 Canada Country Macro Economic Indicators |
3.2 Canada Companion Diagnostic Tests in Oncology Market Revenues & Volume, 2021 & 2031F |
3.3 Canada Companion Diagnostic Tests in Oncology Market - Industry Life Cycle |
3.4 Canada Companion Diagnostic Tests in Oncology Market - Porter's Five Forces |
3.5 Canada Companion Diagnostic Tests in Oncology Market Revenues & Volume Share, By Detection Technique, 2021 & 2031F |
3.6 Canada Companion Diagnostic Tests in Oncology Market Revenues & Volume Share, By Biomarker, 2021 & 2031F |
3.7 Canada Companion Diagnostic Tests in Oncology Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
3.8 Canada Companion Diagnostic Tests in Oncology Market Revenues & Volume Share, By End-user, 2021 & 2031F |
4 Canada Companion Diagnostic Tests in Oncology Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Canada |
4.2.2 Growing demand for personalized medicine in oncology |
4.2.3 Technological advancements in diagnostic testing |
4.2.4 Supportive government initiatives and funding for oncology research |
4.3 Market Restraints |
4.3.1 Regulatory challenges and approval process for companion diagnostic tests |
4.3.2 High cost associated with companion diagnostic tests |
4.3.3 Limited accessibility to advanced diagnostic technologies in certain regions of Canada |
5 Canada Companion Diagnostic Tests in Oncology Market Trends |
6 Canada Companion Diagnostic Tests in Oncology Market, By Types |
6.1 Canada Companion Diagnostic Tests in Oncology Market, By Detection Technique |
6.1.1 Overview and Analysis |
6.1.2 Canada Companion Diagnostic Tests in Oncology Market Revenues & Volume, By Detection Technique, 2021- 2031F |
6.1.3 Canada Companion Diagnostic Tests in Oncology Market Revenues & Volume, By DNA Detection, 2021- 2031F |
6.1.4 Canada Companion Diagnostic Tests in Oncology Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Canada Companion Diagnostic Tests in Oncology Market, By Biomarker |
6.2.1 Overview and Analysis |
6.2.2 Canada Companion Diagnostic Tests in Oncology Market Revenues & Volume, By EGFR, 2021- 2031F |
6.2.3 Canada Companion Diagnostic Tests in Oncology Market Revenues & Volume, By KRAS, 2021- 2031F |
6.2.4 Canada Companion Diagnostic Tests in Oncology Market Revenues & Volume, By HER2, 2021- 2031F |
6.2.5 Canada Companion Diagnostic Tests in Oncology Market Revenues & Volume, By BRAF V600E, 2021- 2031F |
6.2.6 Canada Companion Diagnostic Tests in Oncology Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Canada Companion Diagnostic Tests in Oncology Market, By Cancer Type |
6.3.1 Overview and Analysis |
6.3.2 Canada Companion Diagnostic Tests in Oncology Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.3.3 Canada Companion Diagnostic Tests in Oncology Market Revenues & Volume, By Lung Cancer, 2021- 2031F |
6.3.4 Canada Companion Diagnostic Tests in Oncology Market Revenues & Volume, By Colorectal Cancer, 2021- 2031F |
6.3.5 Canada Companion Diagnostic Tests in Oncology Market Revenues & Volume, By Liver Cancer, 2021- 2031F |
6.3.6 Canada Companion Diagnostic Tests in Oncology Market Revenues & Volume, By Melanoma, 2021- 2031F |
6.3.7 Canada Companion Diagnostic Tests in Oncology Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Canada Companion Diagnostic Tests in Oncology Market, By End-user |
6.4.1 Overview and Analysis |
6.4.2 Canada Companion Diagnostic Tests in Oncology Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Canada Companion Diagnostic Tests in Oncology Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.4 Canada Companion Diagnostic Tests in Oncology Market Revenues & Volume, By Diagnostic Labs, 2021- 2031F |
6.4.5 Canada Companion Diagnostic Tests in Oncology Market Revenues & Volume, By Others, 2021- 2031F |
7 Canada Companion Diagnostic Tests in Oncology Market Import-Export Trade Statistics |
7.1 Canada Companion Diagnostic Tests in Oncology Market Export to Major Countries |
7.2 Canada Companion Diagnostic Tests in Oncology Market Imports from Major Countries |
8 Canada Companion Diagnostic Tests in Oncology Market Key Performance Indicators |
8.1 Adoption rate of companion diagnostic tests in oncology |
8.2 Rate of integration of companion diagnostic tests in treatment decision-making process |
8.3 Number of partnerships and collaborations between diagnostic test providers and oncology treatment centers |
8.4 Level of reimbursement coverage for companion diagnostic tests by healthcare payers |
9 Canada Companion Diagnostic Tests in Oncology Market - Opportunity Assessment |
9.1 Canada Companion Diagnostic Tests in Oncology Market Opportunity Assessment, By Detection Technique, 2021 & 2031F |
9.2 Canada Companion Diagnostic Tests in Oncology Market Opportunity Assessment, By Biomarker, 2021 & 2031F |
9.3 Canada Companion Diagnostic Tests in Oncology Market Opportunity Assessment, By Cancer Type, 2021 & 2031F |
9.4 Canada Companion Diagnostic Tests in Oncology Market Opportunity Assessment, By End-user, 2021 & 2031F |
10 Canada Companion Diagnostic Tests in Oncology Market - Competitive Landscape |
10.1 Canada Companion Diagnostic Tests in Oncology Market Revenue Share, By Companies, 2024 |
10.2 Canada Companion Diagnostic Tests in Oncology Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |